Refreshing results…
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
UploadThe TP53 Apoptotic Network is a Primary Mediator of Resistance to BCL2 inhibition in AML Cells
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.